Skip to main content
Tulane Home Tulane Home

Tumor Biology & Signaling

Normal cells have a complex series of molecular signals that allow communication between cells as well as transmittal of signals to the cell nucleus. These signals are critical for regulating cell growth, apoptosis, angiogenesis and immune avoidance of the tumor. Changes in the signaling pathways, either through mutation or changes in gene expression, are necessary for tumor growth. These aberrant signaling pathways, both in the tumor and in normal tissues, represent ideal targets for therapeutic intervention in translational cancer research.

Tulane Cancer Center Program Faculty Members in Clinical and Translational Research Program Include….

Asim Abdel-Mageed, DVM, Ph.D.
Vecihi Batuman, M.D.
David Blask, M.D., Ph.D.
Matthew Burow, Ph.D.
Bridgette Collins-Burow, M.D., Ph.D.
David Coy, Ph.D.
Srikanta Dash, Ph.D.
Yan Dong, Ph.D.
Samir El-Dahr, Ph.D.
David Franklin, Ph.D.
Chang Han, M.D., Ph.D.
Steven Hill, PH.D. – Program Leader

S. Michal Jazwinski, Ph.D.
Joseph Lasky, M.D.
John McLachlan, Ph.D.
Charles Miller, III, Ph.D.
Cindy Morris, Ph.D.
Brian Rowan, Ph.D.
Oliver Sartor, M.D.
Deborah Sullivan, Ph.D.
William Wimley, Ph.D.
Tong Wu, M.D., Ph.D.
Zongbing You, M.D., Ph.D.
Haitao Zhang, Ph.D.